摘要目的 蛇葡萄素是存在于植物藤茶中含量非常高的黄酮类化合物，本研究主要探讨抑制Akt-mTOR/PKM2介导的糖酵解在蛇葡萄素诱导乳腺癌细胞增殖抑制中的作用。方法 不同浓度蛇葡萄素（20、40、60和80μmol/L）分别处理MDA-MB-231、MCF-7人乳腺癌细胞24h后，CCK-8检测乳腺癌细胞活力，2-NBDG法检测细胞糖摄取能力，比色法检测细胞培养液中乳酸含量，Western blot 检测相关分子蛋白的表达。结果 蛇葡萄素可显著抑制乳腺癌细胞的增殖（P<0.05），且随着蛇葡萄素处理剂量的增加，乳腺癌细胞增殖抑制增强（P<0.05），提示蛇葡萄素诱导乳腺癌细胞增殖抑制作用存在明显的剂量效应关系。进一步研究发现，蛇葡萄素可剂量依赖性的降低乳腺癌细胞的糖摄取能力（P<0.05），并显著减少乳腺癌细胞乳酸生成（P<0.05）。Western blot 检测发现，蛇葡萄素在显著下调Akt-mTOR信号通路中p-Akt、p-mTOR、p-p70S6K等蛋白表达水平的同时下调与糖酵解相关分子GLUTI、LDHA、PKM2的蛋白表达水平。预先给予Akt-mTOR信号通路诱导剂IGF-1，以上作用均可被显著削弱。结论 蛇葡萄素可抑制乳腺癌增殖，该作用与其抑制Akt-mTOR信号通路、进而抑制乳腺癌细胞糖酵解有关，本研究结果可为蛇葡萄素抗肿瘤作用机制提供了一种新的解释。
Abstract：Objective To explore whether AMP， a flavonol mainly found in Ampelopsis grossedentata， induces cell growth inhibition by suppressing glycolysis through Akt-mTOR/PKM2 pathway in breast cancer cells. Methods After MCF-7 and MDA- MB-231 breast cancer cells treated with 20， 40， 60 and 80μmol/L AMP for 24h， cell viability was assessed by CCK-8 assay， glucose uptake assay was performed using 2-NBDG， lactate levels were measured using the colorimetric lactate assay kit and the protein expressions were assessed by Western blot. Results AMP treatment could inhibit cell viability in MCF-7 and MDA- MB-231 breast cancer cells in dose-dependent manners. The further experiments exhibited that AMP successfully blocked cell glycolysis by inhibiting the level of glucose uptake and the production of lactic acid， decreased the level of glycolysis-related proteins pyruvate kinase M2 (PKM2)， glucose transporter1 (GLUT1) and lactate dehydrogenase A (LDHA)， and also inactivated the Akt-mTOR pathway by down-regulation of p-Akt、p-mTOR、p-p70S6K expressions. However， Akt-mTOR pathway inducer IGF-1 treatment significantly attenuated AMP- induced above mentioned results. Conclusion AMP suppressed breast cancer cell growth and glycolysis through inhibiting Akt-mTOR/PKM2 pathway， and may provide a potential therapeutic target for breast cancer treatment.
周永，郑金英，徐小华，金小玲. 抑制PKM2介导的糖酵解在蛇葡萄素抗乳腺癌增殖中的作用[J]. 肿瘤代谢与营养电子杂志, 2019, 6(2): 236-241.
ZHOU Yong， ZHENG Jin-ying， XU Xiao-hua， JIN Xiao-ling. Ampelopsin induces cell growth inhibition in breast cancer cells by suppressing pyruvate kinase M2-dependent glycolysis. Electron J Metab Nutr Cancer, 2019, 6(2): 236-241.
1.Qureshi AS， Ali S. Review: Warburg effect and renal cancer caused by errs in fumarate hydratase encoding gene. Pak J Pharm Sci. 2019；32(2):743-749.
2.Liu Y， Zhang Z， Wang J， et al. Metabolic reprogramming results in abnormal glycolysis in gastric cancer: a review. Onco Targets Ther. 2019；12:1195-1204.
3.Zheng YL， Li L， Jia YX， et al. LINC01554-mediated glucose metabolism reprogramming suppresses tumorigenicity in hepatocellular carcinoma via downregulating PKM2 expression and inhibiting Akt/mTOR signaling pathway.Theranostics. 2019；9(3):796-810.
4.Siddiqui FA， Prakasam G， Chattopadhyay S， et al. Curcumin decreases Warburg effect in cancer cells by down-regulating pyruvate kinase M2 via mTOR-HIF1α inhibition. Sci Rep. 2018；8(1):8323-8331.
5.Tao T， Su Q， Xu S， et al. Down-regulation of PKM2 decreases FASN expression in bladder cancer cells through AKT/mTOR/SREBP-1c axis. J Cell Physiol. 2019；234(3):3088-3104.
6.Xiaoyu H， Yiru Y， Shuisheng S， et al. The mTOR pathway regulates PKM2 to affect glycolysis in esophageal squamous cell carcinoma. Technol Cancer Res Treat. 2018；17:1-10.
7.Luis C， Duarte F， Faria I， et al. Warburg effect inversion: adiposity shifts central primary metabolism in MCF-7 breast cancer cells. Life Sci. 2019；223:38-46.
8.Amin S， Yang P， Li Z. Pyruvate kinase M2: A multifarious enzyme in non-canonical localization to promote cancer progression. Biochim Biophys Acta Rev Cancer. 2019；1871(2):331-341.
9.Rossi M， Strikoudi P， Spei ME， et al. Flavonoids and bladder cancer risk. Cancer Causes Control. 2019；30(5):527-535.
10.Kashyap D， Garg VK， Tuli HS， et al. Fisetin and quercetin: promising flavonoids with chemopreventive potential.Biomolecules. 2019；9(5):174-175
11.Aslan E， Guler C， Adem S. In vitro effects of some flavonoids and phenolic acids on human pyruvate kinase isoenzyme M2. J Enzyme Inhib Med Chem. 2016；31(2):314-317.
12.Jia L， Huang S， Yin X， et al. Quercetin suppresses the mobility of breast cancer by suppressing glycolysis through Akt-mTOR pathway mediated autophagy induction. Life Sci. 2018；208:123-130.
13.宁涛，巴一.肿瘤生长与转移的代谢基础.肿瘤代谢与营养电子杂志. 2017；4(4):371-375.
14.Zhou Y， Liang X， Chang H， et al. Ampelopsin-induced autophagy protects breast cancer cells from apoptosis through Akt-mTOR pathway via endoplasmic reticulum stress. Cancer Sci. 2014；105(10):1279-1287.
15.Zhu H， Wu J， Zhang W， et al. PKM2 enhances chemosensitivity to cisplatin through interaction with the mTOR pathway in cervical cancer. Sci Rep. 2016；6:30788-30798.
16.Ye G， Qin Y， Wang S， et al. Lamc1 promotes the Warburg effect in hepatocellular carcinoma cells by regulating PKM2 expression through AKT pathway. Cancer Biol Ther. 2019；20(5):711-719.
17.Pinheiro C， Granja S， Longatto-Filho A， et al. GLUT1 expression in pediatric adrenocortical tumors: a promising candidate to predict clinical behavior. Oncotarget. 2017；8(38):63835-63845.
18.Lin C， Xu X. YAP1-TEAD1-Glut1 axis dictates the oncogenic phenotypes of breast cancer cells by modulating glycolysis. Biomed Pharmacother. 2017；95:789-794.
19.Chen TY， Hsieh YT， Huang JM， et al. Determination of pyruvate metabolic fates modulates head and neck tumorigenesis.Neoplasia. 2019；21(7):641-652.
20.Wang H， Peng R， Chen X， et al. Effect of HK2， PKM2 and LDHA on Cetuximab efficacy in metastatic colorectal cancer.Oncol Lett. 2018；15(4):5553-5560.
21.Huang C， Huang YL， Wang CC， et al. Ampelopsins A and C induce apoptosis and metastasis through downregulating AxL， TYRO3， and FYN expressions in MDA-MB-231 breast cancer cells.J Agric Food Chem. 2019；67(10):2818-2830.
22.Ayuk SM， Abrahamse H. mTOR signaling pathway in cancer targets photodynamic therapy in vitro.Cells. 2019；8(5):431-443.
23.Bossler F， Hoppe-Seyler K， Hoppe-Seyler F. PI3K/akt/mtor signaling regulates the virus/host cell crosstalk in HPV-positive cervical cancer cells.Int J Mol Sci. 2019；20(9):2188-2199.
24.Cui XL， Li KJ， Ren HX， et al. Extract of Cycas revoluta Thunb. enhances the inhibitory effect of 5-uorouracil on gastric cancer cells through the AKT-mTOR pathway.World J Gastroenterol. 2019；25(15):1854-1864.
25.Chen YL， Lin HW， Sun NY， et al. Mtor inhibitors can enhance the anti-tumor effects of dna vaccines through modulating dendritic cell function in the tumor microenvironment.Cancers (Basel). 2019；11(5):617-626.
26.Yasumizu Y， Hongo H， Kosaka T， et al. PKM2 under hypoxic environment causes resistance to mTOR inhibitor in human castration resistant prostate cancer. Oncotarget. 2018；9(45):27698-27707.
27.Son JY， Yoon S， Tae IH， et al. Novel therapeutic roles of MC-4 in combination with everolimus against advanced renal cell carcinoma by dual targeting of Akt/pyruvate kinase muscle isozyme M2 and mechanistic target of rapamycin complex 1 pathways.Cancer Med. 2018； 7(10):5083-5095.
